TrialThe oncologist2016

Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study.

San-Chi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.